NCT03737838View on ClinicalTrials.gov

Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Atrial Fibrillation
Interventions
DEVICE

Atrial fibrillation ablation

High density mapping of left atrium using Rhythmia mapping system to identify gaps in conduction and wavefront discontinuities (deceleration zones)

Trial Locations (1)

60637

The University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03737838 - Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF) | Biotech Hunter | Biotech Hunter